Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Pediatr ; 132(1): 15-21, 1998 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9469994

RESUMEN

OBJECTIVE: DiGeorge syndrome is characterized by developmental defects of the heart, parathyroid glands, and thymus. The objective of this study was to determine whether T-cell function spontaneously improves in patients with DiGeorge syndrome who have profoundly depressed T-cell proliferative responses to mitogens at presentation, regardless of the T-cell count. STUDY DESIGN: We conducted a retrospective chart review of eight patients with DiGeorge syndrome who had no proliferative responses to mitogens on presentation. RESULTS: Despite lack of responsiveness of the patients' peripheral blood lymphocytes to mitogens, T cells were occasionally detected, and the patients' cells often responded to IL-2 and in mixed lymphocyte reactions. Unresponsiveness to mitogens and clinical immunodeficiency persisted without immune-based therapy. One patient is alive and well after immunoreconstitution from thymic transplantation. The others either died early of complications of their disease such as gastroesophageal reflux with aspiration (2 patients) or infection (2 patients) or died after attempts at immunorestorative therapy with IL-2, thymus transplantation, or bone marrow transplantation (3 patients). CONCLUSION: Eight patients with DiGeorge syndrome who were first seen with no mitogen responsiveness did not improve spontaneously. We recommend HLA-identical bone marrow transplantation or thymic transplantation for these patients as soon as the diagnosis is confirmed.


Asunto(s)
Síndrome de DiGeorge/inmunología , Activación de Linfocitos , Linfocitos T/inmunología , Trasplante de Médula Ósea , Complejo CD3 , Antígenos CD4 , Antígenos CD8 , Preescolar , Síndrome de DiGeorge/diagnóstico , Síndrome de DiGeorge/terapia , Resultado Fatal , Citometría de Flujo , Enfermedad Injerto contra Huésped , Humanos , Inmunoglobulinas/sangre , Lactante , Interleucina-2/uso terapéutico , Recuento de Linfocitos , Estudios Retrospectivos , Timo/trasplante
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA